Glooko launches GestationalCare for pregnancy diabetes management
Glooko announced the launch of GestationalCare, a pregnancy-specific module supporting diabetes management for patients with gestational, Type 1, or Type 2 diabetes. Available in the UK and expected to launch in the U.S. in October 2026, the solution helps care teams monitor glucose patterns, identify high-risk patients, engage patients between visits, and support postpartum care.
Medibyt receives FDA clearance for CPETWise
Medibyt received FDA 510(k) clearance for CPETWise, an intelligent platform designed to streamline cardiopulmonary exercise testing (CPET) analysis, interpretation, and reporting. The clearance enables U.S. commercialization following a 100-case University of Washington study that reported more than a 50% reduction in interpretation time. Medibyt plans to expand CPETWise internationally and into additional cardiopulmonary diagnostics.
Solera Health adds Noom to weight management network
Solera Health has partnered with Noom to expand its digital-first weight management network for health plans and employers. The partnership adds Noom Weight, its CDC Full Plus-recognized Diabetes Prevention Program, and a GLP-1 Companion program at no additional cost. The collaboration strengthens Solera’s network with a self-guided, app-based option focused on sustainable weight management and diabetes prevention.
Planned Parenthood Direct expands telehealth HSV care
Planned Parenthood Direct has expanded telehealth treatment for diagnosed HSV-1 and HSV-2 across 26 states and Washington, DC, including Maryland and Virginia. Through the PPDirect app, licensed providers review confidential health questionnaires and prescribe treatment for active outbreaks or prevention when appropriate. The service aims to improve access to ongoing HSV management while reducing geographic, logistical, and stigma-related barriers to care.
